Angiotensin converting enzyme inhibitor or angiotensin receptor blocker use among hypertensive US adults with albuminuria

Since 2003, US hypertension guidelines have recommended angiotensin converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB) as first-line antihypertensive therapy in the presence of albuminuria (urine albumin/creatinine ratio ≥300 mg/g). To examine national trends in guideline-con...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hypertension
Autors principals: Chu, Chi D., Powe, Neil R., McCulloch, Charles E., Banerjee, Tanushree, Crews, Deidra C., Saran, Rajiv, Bragg-Gresham, Jennifer, Morgenstern, Hal, Pavkov, Meda E., Saydah, Sharon H., Tuot, Delphine S.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7725867/
https://ncbi.nlm.nih.gov/pubmed/33190561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/HYPERTENSIONAHA.120.16281
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars